Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-07-11)Premium Content

Glaxosmithkline Plc (GSK)

2014-09-17@13:20:57 ET
GlaxoSmithKline PLC (GSK) Trading Near $47.71 Resistance Level (FBM)

2014-09-17@10:04:35 ET
Mylan initiates Phase III asthma and diabetes trials (DTM)

2014-09-17@09:21:50 ET
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry - 2014 (MTO)

2014-09-17@07:47:47 ET
Mylan commences two Phase III clinical trials for insulin analog programme, marking important milestone in development of two highly complex products (MTO)

2014-09-17@01:08:16 ET
GlaxoSmithKline's law firm in Hong Kong just poached a US prosecutor to deal with corruption cases (ABW)

2014-09-16@09:59:21 ET
Global Chronic Cough Therapeutics Pipeline Review 2014 - 7 Companies & 7 Drug Profiles (MTO)

2014-09-16@07:30:00 ET
(PRN)

2014-09-15@16:39:32 ET
Five Prime Therapeutics Announces Option Exercise by GlaxoSmithKline for a Commercial License to a Novel Muscle Disease Target (PMZ)

2014-09-15@10:37:34 ET
Europe ADRs Slightly Lower Ahead of Federal Reserve Policy Meet; Crude Futures Weigh on Oil Producers (MID)

2014-09-15@10:23:43 ET
GlaxoSmithKline PLC (GSK) Showing Bearish Technicals With Support At $46.79 (FBM)

2014-09-12@09:10:00 ET
Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale (PRN)

2014-09-12@08:13:46 ET
GlaxoSmithKline PLC (GSK) Trading Near $47.25 Resistance Level (FBM)

2014-09-12@07:53:36 ET
Global Asthma Market 2014-2018: Leading Vendors are AstraZeneca, F. Hoffmann-La Roche, GSK, Merck & Novartis (MTO)

2014-09-12@04:41:58 ET
Gastrointestinal Stromal Tumor (GIST) Therapeutics Pipeline Review 2014 - 13 Companies & 24 Drug Profiles (MTO)

2014-07-23@21:26:52 ET
GlaxoSmithKline plcCorporate Event Announcement Notice (WSH)

2014-07-23@16:51:21 ET
SmarTrend Watching for Potential Rebound in Shares of GlaxoSmithKline After 5.98% Loss (PSM)

2014-07-23@16:50:51 ET
Watch for GlaxoSmithKline to Potentially Rebound After Falling 5.98% Yesterday (PSM)

2014-07-23@14:24:36 ET
Wednesday's ETF with Unusual Volume: PPH (MNV)

2014-07-23@14:04:14 ET
GlaxoSmithKline PLC (GSK) Showing Bearish Technicals With Support At $52.96 (FBM)

2014-07-23@14:03:55 ET
Shares of GlaxoSmithKline Are Moving Lower on 5.1x Above-Average Volume (GSK) (F82)